Shanghai Weimu Medical Technology Co., Ltd. announced that it has raised over CNY 100 million in a round of funding co-led by new investors, Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd. on December 6, 2023. The transaction included participation from new investors, SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, and returning investors, Jiaxing Woyong Investment Partnership Enterprise (LP) a fund managed by Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
57.3 CNY | +3.52% | +2.08% | -15.95% |
Apr. 29 | Jefferies Adjusts Yunnan Botanee Bio-Technology’s Price Target to 62 Yuan From 87 Yuan, Keeps at Hold | MT |
Apr. 26 | Yunnan Botanee Bio-Technology Group Co.LTD Proposes Final Dividend for 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.95% | 3.21B | |
+11.48% | 18.86B | |
0.00% | 17.37B | |
-0.49% | 10.65B | |
-7.25% | 10.26B | |
+7.52% | 6.72B | |
+10.34% | 5.94B | |
-0.06% | 4.55B | |
-18.21% | 3.83B | |
-3.97% | 3.48B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Shanghai Weimu Medical Technology Co., Ltd. announced that it has received CNY 100 million in funding from Yunnan Botanee Bio-Technology Group Co.LTD, Huajin Avenue Investment Co., Ltd., SHAREWIN Equity Investment and Management Co., Ltd., Shanghai CS Capital Co., Ltd, Sinvo Capital Holdings Co., Ltd., Investment Arm, IDG Capital Partners Co., Ltd.